Neurotensin
CAS No. 39379-15-2
Neurotensin( —— )
Catalog No. M30009 CAS No. 39379-15-2
Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 72 | In Stock |
|
| 5MG | 146 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 412 | In Stock |
|
| 50MG | 593 | In Stock |
|
| 100MG | 833 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameNeurotensin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
-
DescriptionNeurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNeurotensin receptors (NTR)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39379-15-2
-
Formula Weight1672.92
-
Molecular FormulaC78H121N21O20
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 33.33 mg/mL (19.92 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
1-Methyl-hydantoin
1-Methylhydantoin is a small molecular weight polar substance the product of degradation of creatinine by bacteria. In mammals the metabolism of 1-methylhydantoin occurs via 5-hydroxy-1-methylhydantoin. In a reported human case 1-Methylhydantoin was found as an unexpected metabolite of the intelligence-affecting substance dupracetam.
-
Stepharine
Alkaloids.
-
PSB-15160
PSB-15160 is a compound that inhibits the growth of MCF7 (breast), NCI-H460 (lung) and SF-268 (NCS) cells in the treatment of estrogen-dependent tumours.
Cart
sales@molnova.com